Is HAS Healthcare Advanced Synthesis SA FDA approved?

HAS Healthcare Advanced Synthesis SA holds 1 FDA-registered establishment in Switzerland. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are HAS Healthcare Advanced Synthesis SA's drugs manufactured?

The FDA register lists Biasca. Registered operations: analytical testing, active ingredient (API) manufacture, finished drug manufacture.

What drugs does HAS Healthcare Advanced Synthesis SA make?

11 products are listed under HAS Healthcare Advanced Synthesis SA in the openFDA NDC Directory, most often as powder; liquid; powder, for solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

HAS Healthcare Advanced Synthesis SA

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 1
Active NDC listings: 11
Labeller names: 2
Live patents: 0
Countries: 1
Base: Switzerland

Authorisation

Registered operations

Analytical testing1Active ingredient (API) manufacture1Finished drug manufacture1

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
HAS Healthcare Advanced Synthesis SA	Via Industria 24, Biasca, Ticino 6710, Switzerland (CHE)	Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture	3002807151481296960

Catalogue

Drug listings by form and route

11 active NDC listings: 11 bulk ingredient. By marketing category: BULK INGREDIENT 11.

Dosage form	NDCs
powder	8
liquid	2
powder, for solution	1

Route	NDCs

Labeller name on the listing	NDCs
has healthcare advanced synthesis sa	10
has healthcare advanced synthesis sa	1

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
-	Anamorelin Hydrochloride	powder	67262-0006BULK INGREDIENT
-	Bexarotene	powder	67262-0005BULK INGREDIENT
-	Carfilzomib	powder, for solution	67262-0010BULK INGREDIENT
-	Crinecerfont	powder	67262-5000BULK INGREDIENT
-	Cysteamine Hydrochloride	powder	67262-0007BULK INGREDIENT
-	Dantrolene Sodium	powder	67262-2000BULK INGREDIENT
-	Glycerol Phenylbutyrate	liquid	67262-0008BULK INGREDIENT
-	Glycerol Phenylbutyrate	liquid	67262-0009BULK INGREDIENT
-	Isotretinoin	powder	67262-0003BULK INGREDIENT
-	Lofexidine Hydrochloride	powder	67262-0011BULK INGREDIENT
-	Palonosetron Hydrochloride	powder	67262-0001BULK INGREDIENT

Compare

Comparable companies in Switzerland

Herbamed AG1 site · 173 NDC
Ricola Ag1 site · 84 NDC
Avyxa GmbH1 site · 29 NDC
Bachem AG1 site · 23 NDC
Vifor (International) AG1 site · 22 NDC
DOTTIKON EXCLUSIVE SYNTHESIS AG1 site · 16 NDC
Cerbios-Pharma SA1 site · 9 NDC
SINTETICA S.A.1 site · 9 NDC
Similasan AG1 site · 7 NDC
Swiss Caps AG1 site · 6 NDC

Enquiry

Common questions

Is HAS Healthcare Advanced Synthesis SA FDA approved?: HAS Healthcare Advanced Synthesis SA holds 1 FDA-registered establishment in Switzerland. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are HAS Healthcare Advanced Synthesis SA's drugs manufactured?: The FDA register lists Biasca. Registered operations: analytical testing, active ingredient (API) manufacture, finished drug manufacture.
What drugs does HAS Healthcare Advanced Synthesis SA make?: 11 products are listed under HAS Healthcare Advanced Synthesis SA in the openFDA NDC Directory, most often as powder; liquid; powder, for solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.